Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW37W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,453
Award facts
- Contract value 100% obligated
- $29,452.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a contract ceiling value of $29,452.92. The order was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, under a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded orders for brand-name and generic pharmaceuticals across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies. This particular delivery order for Ozempic, a diabetes management medication, reflects the company's ongoing role in supplying pharmaceutical products to support Defense Health Agency and other federal healthcare customers through DLA's flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FW37W?
SPE2DR26FW37W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FW37W worth?
The government has obligated $29,453 on SPE2DR26FW37W.
Is contract SPE2DR26FW37W an order under another contract?
Yes. SPE2DR26FW37W is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW37W competed?
The extent of competition for SPE2DR26FW37W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award